Search Results 151-160 of 16854 for CLL
-
Nowakowski is focused on the identification of novel prognostic markers in chronic lymphocytic leukemia using phage display peptide libraries. Dr ...
-
Chronic lymphocytic leukemia · Cutaneous B-cell lymphoma · Cutaneous T-cell lymphoma · Follicular lymphoma · Waldenstrom macroglobulinemia. Symptoms. Signs and ...
-
A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.
-
Lisocabtagene maraleucel injection is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have ...
-
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
-
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index. Blood Cancer J 2021 ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...
-
... Chronic Lymphocytic Leukemia Rochester, MN. The purpose of this study is to ... CLL as well as non-CLL patients. Study to Validate Methods Assessment of ...
-
... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...